Evaxion Biotech A/S (EVAX) Ownership

$2.59

$0.01 (-0.19%)
Last update: 04:00 PM EST
Day's range
$2.49
Day's range
$2.84

Evaxion Biotech A/S Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LM ADVISORS LLC 02/14/2024 337.34 K $231.31 K   100.00% 12.20%
BEACON CAPITAL MANAGEMENT, LLC 01/09/2024 48.63 K $40.51 K   606.77% 1.76%
CITADEL ADVISORS LLC 02/14/2024 42.80 K $29.35 K   100.00% 1.55%
CITADEL ADVISORS LLC 02/14/2024 24.63 K $16.89 K   100.00% 0.89%
RENAISSANCE TECHNOLOGIES LLC 02/13/2024 14.00 K $10.00 K   100.00% 0.51%
JPMORGAN CHASE & CO 12/26/2024 9.00 K $6.17 K   -3.08% 0.33%
RHUMBLINE ADVISERS 02/08/2024 2.91 K $2.00 K   37.93% 0.11%
CITADEL ADVISORS LLC 02/14/2024 1.30 K $891   100.00% 0.05%
GROUP ONE TRADING, L.P. 02/14/2024 386 $265   0.00% 0.01%
UBS GROUP AG 02/09/2024 277 $190   -93.08% 0.01%
MORGAN STANLEY 08/16/2024 0 $0   -100.00% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2024 0 $0   -100.00% 0.00%
TWO SIGMA SECURITIES, LLC 02/14/2024 0 $0   -100.00% 0.00%
AE WEALTH MANAGEMENT LLC 02/14/2024 0 $0   -100.00% 0.00%
MOLONEY SECURITIES ASSET MANAGEMENT, LLC 01/30/2024 0 $0   -100.00% 0.00%

Evaxion Biotech A/S institutional Ownership - FAQ's

During the previous two years, 1 institutional investors and hedge funds held shares of Evaxion Biotech A/S. The most heavily invested institutionals were:

Telemetry Investments, L.L.C.: 37,500

15.81% of Evaxion Biotech A/S stock is owned by institutional investors.

Institutional investors have bought a total of 37.50 K shares in the last 24 months. This purchase volume represents approximately $96.94 K in transactions.